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Background: Nigeria has made notable gains in improving childhood survival but the country still accounts for a
large portion of the world’s overall disease burden, particularly among women and children. To date, no systematic
analyses have comprehensively assessed trends for health outcomes and interventions across states in Nigeria.
Methods: We extracted data from 19 surveys to generate estimates for 20 key maternal and child health (MCH)
interventions and outcomes for 36 states and the Federal Capital Territory from 2000 to 2013. Source-specific estimates
were generated for each indicator, after which a two-step statistical model was applied using a mixed-effects model
followed by Gaussian process regression to produce state-level trends. National estimates were calculated by
population-weighting state values.
Results: Under-5 mortality decreased in all states from 2000 to 2013, but a large gap remained across them. Malaria
intervention coverage stayed low despite increases between 2009 and 2013, largely driven by rising rates of
insecticide-treated net ownership. Overall, vaccination coverage improved, with notable increases in the coverage
of three-dose oral polio vaccine. Nevertheless, immunization coverage remained low for most vaccines, including
measles. Coverage of other MCH interventions, such as antenatal care and skilled birth attendance, generally
stagnated and even declined in many states, and the range between the lowest- and highest-performing states
remained wide in 2013. Countrywide, a measure of overall intervention coverage increased from 33% in 2000 to
47% in 2013 with considerable variation across states, ranging from 21% in Sokoto to 66% in Ekiti.
Conclusions: We found that Nigeria made notable gains for a subset of MCH indicators between 2000 and 2013,
but also experienced stalled progress and even declines for others. Despite progress for a subset of indicators,
Nigeria’s absolute levels of intervention coverage remained quite low. As Nigeria rolls out its National Health Bill
and seeks to strengthen its delivery of health services, continued monitoring of local health trends will help
policymakers track successes and promptly address challenges as they arise. Subnational benchmarking ought to
occur regularly in Nigeria and throughout sub-Saharan Africa to inform local decision-making and bolster health
system performance.
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Over the last two decades, Nigeria has documented both
progress and challenges in improving the health of its
population [1]. Although under-5 mortality decreased by
38% between 1990 and 2013, 14% of child deaths in the
world still occurred in Nigeria in 2013 [2]. Minimal
gains have occurred for maternal mortality over the past
25 years, with Nigeria’s maternal mortality ratio consist-
ently hovering around 500 deaths per 100,000 live births
since 1990 [3]. In 2013, 30% of the world’s malaria cases
and deaths occurred within Nigeria’s borders [4].
Nigeria and its development partners have made sev-
eral efforts to address the country’s health needs. To
date, investments to scale up polio immunization cam-
paigns and malaria control have been particularly large
[5, 6]; for instance, the Global Polio Eradication Initiative
(GPEI) plans to spend nearly $1.5 billion on efforts in
Nigeria between 2013 and 2018 [7]. Beyond disease-
specific programs, Nigeria has also enacted policies to im-
prove access to and quality of health care [8–16]. In 2014,
the National Health Bill was passed, aiming to strengthen
Nigeria’s primary health care systems, bolster monitoring
and evaluation capacities, and move toward universal health
coverage through improved financial protections [17].
Health policies and programs are typically imple-
mented in a phased manner in Nigeria, largely due to
the country’s large size and decentralized health system
[10, 13, 18]. State governments oversee health funding
and logistic support, whereas local government areas
(LGAs) are the geographic units from which primary
health services are provided [10, 19]. Historically, LGAs
have been under-funded and operate with less capacity
to implement health initiatives than originally planned
[20]. In combination with the country’s large and diverse
population, it often takes years before interventions have
reached all states. For instance, over a third of states
rolled-out the pentavalent vaccine two years after it was
originally introduced in the country [21], while mass dis-
tribution campaigns for long-lasting insecticide-treated
nets (LLINs) occurred state by state between 2008 and
2014 [6, 22, 23]. This highlights the need to track and
assess trends in intervention coverage and health out-
comes at the subnational level in Nigeria.
A number of other populous countries, such as Mexico
and Brazil, have been successful in using subnational
benchmarking exercises to inform policy decisions and
program priorities [24–26]. Although efforts have been
made to synthesize subnational health information in
Nigeria, these data have not often been comparable over
time, nor have they presented the country’s full geography
[13, 27–32]. Recently, there have been efforts to develop a
LGA-level tool for evaluating progress on health, educa-
tion, and environmental indicators by Nigeria’s Millennium
Development Goal (MDG) office [33], a critical step toimproving subnational monitoring systems. However, this
tool shows information for each indicator for only 1 year
and thus cannot provide an understanding of trends over
time – a vital component to capturing the effects of
specific health policies and programs.
By synthesizing data from multiple sources, we provide
the first-ever analysis of state-level trends for a range of
Nigeria’s key maternal and child health (MCH) outcomes
and interventions from 2000 to 2013.
Methods
Indicator selection
We identified 20 MCH outcomes and interventions based
on their relevance to Nigeria’s health priorities and data
availability at the state-level. These indicators included child
health outcomes (all-cause under-5 mortality; the propor-
tion of children under 5 who were underweight; the preva-
lence of wasting among children under 5; the prevalence of
stunting among children under 5), malaria interventions
(household ownership of at least one insecticide-treated net
[ITN]; ITN use by children under 5; the proportion of
households owning at least one ITN or having received in-
door residual spraying [IRS]; intermittent preventative ther-
apy for malaria during pregnancy, two doses [IPTp2]; the
proportion of children who received artemisinin-based
combination therapies [ACTs] in response to having a
fever), immunizations (the Bacillus Calmette-Guérin [BCG]
vaccine; measles vaccine; three doses of the diphtheria-
pertussis-tetanus vaccine [DPT3]; three doses of the oral
polio vaccine [OPV3]), and other key MCH interventions
(one and four antenatal care visits [ANC1 and ANC4];
skilled birth attendance [SBA]; rates of in-facility deliveries
[IFD]; exclusive breastfeeding [EBF]; modern contraception
use; and the receipt of at least two doses of the tetanus tox-
oid vaccine during pregnancy). State-level data were not
available for HIV/AIDS treatment. Table 1 provides defini-
tions for each indicator. We focus on a subset of these indi-
cators in this paper, but present results for all indicators in
Additional files 1 and 2, as well as through an interactive
data visualization tool [34].
Data
We conducted a comprehensive search of all available
state-level survey data for Nigeria, including targeted lit-
erature reviews, indexed data files stored in the Global
Health Data Exchange (GHDx) [35], and source-specific
requests made to organizations and ministries. All data
files extracted from the GHDx are publicly available and
can be directly accessed online: http://ghdx.healthdata.org.
Surveys were excluded if they did not measure any of
the study’s indicators, we could not link units of obser-
vation to a given state, or there were documented con-
cerns about data quality or representativeness (the 1999
Demographic and Health Survey [DHS]; Community
Table 1 Definition of indicators
Indicator (abbreviation) Definition Data sources
Maternal and child health indicators
Antenatal care (ANC1, ANC4) The proportion of women aged 15–49 years who gave birth in
the given year and had one/four or more antenatal visits attended
by skilled personnel (doctor, nurse, midwife, or clinical officer) at a
health facility during the corresponding pregnancy




Skilled birth attendance (SBA) The proportion of women aged 15–49 years who gave birth
in the given year and delivered with a skilled birth attendant
(a doctor, nurse, midwife, or clinical officer)




In-facility deliveries (IFD) The proportion of women aged 15–49 years who gave birth
in a given year and delivered at a health facility
DHS: 2003, 2008, 2013
MICS: 2007, 2011
CWIQ: 2006
Exclusive breastfeeding (EBF) The proportion of children who were exclusively
breastfed during their first six months after birth
DHS: 2003, 2008, 2013
MICS: 1999, 2007, 2011
GHS: 2006, 2007, 2010, 2012
Prevalence of modern contraceptive use The proportion of women aged 15–49 years who
reported using a modern method of contraception
DHS: 2003, 2008, 2013
MICS: 1999, 2007, 2011
GHS: 2006, 2007, 2010, 2012
LSS: 2003–2004, 2009–2010
Percentage of women who received two
or more doses of the tetanus toxoid
vaccine during pregnancy
The proportion of women aged 15–49 years who
received two or more doses of the tetanus
toxoid vaccine during their last pregnancy
DHS: 2003, 2008, 2013
MICS: 2007, 2011
Childhood immunizations
Bacillus Calmette-Guérin immunization (BCG) The proportion of children under 5 who were
vaccinated against tuberculosis in the given year
DHS: 2003, 2008, 2013




The proportion of children aged 12–59 months old who
received three doses of the diphtheria-pertussis-tetanus
(DPT) vaccine in the given year
DHS: 2003, 2008, 2013
MICS: 1999, 2007, 2011
LSS: 2003–2004, 2009–2010
Measles immunization (Measles) The proportion of children aged 12–59 months who
received measles vaccination in the given year
DHS: 2003, 2008, 2013
MICS: 1999, 2007, 2011
LSS: 2003–2004, 2009–2010
Oral polio vaccine immunization, three doses (OPV3) The proportion of children aged 12–59 months who received
three doses of the oral polio vaccine in the given year
DHS: 2003, 2008, 2013
MICS: 1999, 2007, 2011
LSS: 2003–2004, 2009–2010
Malaria interventions
Intermittent preventive therapy for malaria
during pregnancy, two doses (IPTp2)
The proportion of women aged 15–49 years who gave birth
in the given year and received at least two treatment doses
of Fansidar (sulfadoxine/pyrimethamine) at antenatal care
visits during the corresponding pregnancy
DHS: 2003, 2008, 2013
MICS: 2007, 2011
MIS: 2010
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Table 1 Definition of indicators (Continued)
Indicator (abbreviation) Definition Data sources
Malaria interventions
Household ownership of ITNs (ITN own) The proportion of households that own at least one
insecticide-treated net (ITN)




Netmark: 2000, 2004, 2008
ITN use by children under 5 (ITN use) The proportion of children under 5 who slept under
an ITN the previous night




Netmark: 2000, 2004, 2008
Household ownership of ITNs or receipt
of indoor residual spraying (ITN or IRS)
The proportion of households that own at least one
ITN or were sprayed with an insecticide-based
solution in the last 12 months, or both




Netmark: 2000, 2004, 2008
Percentage of febrile children under
5 who received ACTs
The proportion of children under 5 with a fever in the
past two weeks who received artemisinin-based
combination therapies (ACTs) as treatment





Under-5 mortality The probability that a child born in the given year will die
before reaching the age of 5; expressed in terms
of under-5 deaths per 1,000 live births
DHS: 1990, 2003, 2008, 2013
MICS: 1999, 2007, 2011
MIS: 2010
Percentage of children under 5 who are underweight The proportion of children under 5 who are underweight,
as defined by weighing two or more standard deviations
below the international anthropometric reference
population median of weight for age
DHS: 2003, 2008, 2013
MICS: 1999, 2007, 2011
Prevalence of wasting among children under 5 The proportion of children under 5 who are wasting, as
defined by weighing two or more standard deviations
below the international anthropometric reference
population median of weight for height
DHS: 2003, 2008, 2013
MICS: 1999, 2007, 2011
Prevalence of stunting among children under 5 The proportion of children under 5 who are stunted,
as defined by weighing two or more standard deviations
below the international anthropometric reference
population median of height for age
DHS: 2003, 2008, 2013
MICS: 1999, 2007, 2011
CWIQ, Core Wealth Indicator Questionnaire; DHS, Demographic and Health Survey; GHS, General Household Survey; LSS, Living Standards Survey; MICS, Multiple
Indicator Cluster Survey; MIS, Malaria Indicator Survey; Netmark, Netmark Survey; SMART, Standardized Monitoring and Assessment of Relief and Transition
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[36–39]. Preference was always given to microdata, but we
used tabulated state-level findings from survey reports if
the underlying microdata were not available (e.g. the
UNICEF Standardized Monitoring and Assessment of Re-
lief and Transition [SMART] surveys). Nineteen surveys
met inclusion criteria, as documented in Table 1.
MCH indicators
Data processing We produced state-level estimates for
MCH indicators using each data source. For this ana-
lysis, states were defined using current administrativedivisions for 36 states and the Federal Capital Territory
(Abuja) from Nigeria’s National Bureau of Statistics. We
also used regional information to inform our analyses, as
designated by each state’s geopolitical zone (North East,
North Central, North West, South East, South South, South
West). When microdata were available, we accounted for
sampling design by incorporating provided sampling
weights at this step of analysis.
All MCH indicators except for ANC1, ANC4, SBA,
and IFD were extracted as prevalence estimates for the
year of the survey, estimating the state-level mean and
variance for a given survey-year. For ANC1, ANC4, SBA,
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birth of the child. Mothers reported information on
these interventions for each child in the DHS and Core
Wealth Indicator Questionnaire, allowing for the extrac-
tion six years’ worth of data from the survey date [40].
Multiple Indicator Cluster Surveys (MICS) only provided
information on the mother’s most recent birth [41], so
we only extracted data for births within two years of the
survey date to ensure population representativeness.
In cases where data collection and measurement
approaches differed across surveys, we used various
standardization and cross-walking methods to generate
comparable estimates of intervention coverage. For
immunization indicators, some surveys only reported chil-
dren’s vaccination status based on a child health card and
not by both child health cards and a respondent’s self-
report; in these cases, we adjusted state-level estimates of
immunization coverage by applying the average relation-
ship between immunization coverage only based on cards
and total immunization coverage as determined by MICS
and DHS. EBF standardization procedures are described in
further detail by previous work [42].
For malaria interventions, coverage estimates of 0.01%
were applied to years prior to formal policy adoption
and intervention implementation by Nigeria or a given
state. Coverage estimates of 0.01% were used prior to
2001 for IPTp2 [43, 44], as IPTp2 was formally included
in Nigeria’s national guidelines in 2005 but may have
been used during earlier years [45, 46]; prior to 2004 for
ACTs [45] and prior to 2000 for ITN ownership [44].
IRS has been implemented in a phased manner in
Nigeria, so we applied 0.01% coverage prior to 2000 for
all states and then removed this coverage restriction in
accordance with documentation of state-level IRS trials
and subsequent IRS programs [6, 21–23].
Point estimates for each survey were validated by
reviewing survey documentation and reports. We ex-
cluded 3% of the data due to documented sampling is-
sues in certain states or due to implausibility relative to
nearby data points.
Estimating state-level trends
Data were synthesized using a two-stage statistical mod-
eling approach. In the first stage we defined a mean
(prior) function for each indicator using a mixed-effects
model. These results were then fed into a Gaussian
process regression (GPR), a Bayesian model which esti-
mates the posterior distribution of probable trends and
allows for the derivation of median estimates with un-
certainty intervals. We describe the process below in
general terms for all indicators.
To determine the prior mean function for each indica-
tor, we first considered a number of possible specifica-
tions. All proposed models were either linear regressionmodels estimated using ordinary least squares or linear
mixed-effects regression models and varied in terms of
what systematic and random components were in-
cluded. The systematic component included a fixed ef-
fect on time. Year was included in the model either
directly as a single continuous variable or represented
by the bases of a natural cubic spline with a single inter-
ior knot. In the first case, the temporal pattern for the
outcome was assumed to be linear while the second
case allowed for a non-linear temporal pattern and was
consequently more flexible [47]. Independent and iden-
tically distributed (IID) random intercepts and slopes
were tested at the state level and by geopolitical zone.
Dependent variables were logit-transformed to bound
results between 0 and 1.
We used cross-validation to assess the predictive valid-
ity of up to 14 models for each indicator. Below is the
general form of the model:
ys;t ¼ αþ T βþ bs þ bzð Þ þ us þ uz þ εs;t
where ys,t is the logit-transformed indicator for state s in
year t; α is the intercept; T is time, represented either as
linear or using a natural cubic spline; β is the vector of
coefficients for time; bs is an IID random slope on time
for state s; bz is an IID random slope on time for geopol-
itical zone z; us is an IID random intercept with mean
zero for state s; uz is an IID random intercept with mean
zero for geopolitical zone z; εs,t is a normally distributed
error term with mean zero for state s in year t.
For each indicator, we selected the model with the
lowest root-mean squared error as derived from a 20%
random hold-out pattern repeated 100 times.
The median posterior trend and uncertainty were esti-
mated using GPR for each indicator and state. GPR has
been used for similar cross-country and subnational
modelling applications and is explained in detail else-
where [2, 40, 48–50]. We used the estimates generated
in the first stage regression as the mean function with a
covariance structure defined by the Matern covariance
function. We used 1,000 random draws from the poster-
ior distribution to calculate median trends and confi-
dence intervals (CIs), with the latter represented by the
25th and 975th ordered draws. Finally, national-level
trends for each indicator were estimated by population-
weighting state estimates at the draw level.
Under-5 mortality
To estimate trends in under-5 mortality for each state in
Nigeria we applied data processing and synthesis methods
developed previously [51]. Briefly, we extracted one-year
summary and complete birth history data from multiple
surveys (DHS, MICS, and Malaria Indicators Surveys
[MIS]) to estimate source year-specific probabilities of
Wollum et al. BMC Medicine  (2015) 13:208 Page 6 of 16death before the age of 5 years [52]. We then modeled
under-5 mortality trends by applying a one-knot natural
spline model with state and survey IID random effects.
We then population-weighted state-level estimates to gen-
erate a national trend for under-5 mortality [53]. We sys-
tematically compared this national trend with Nigeria-
specific results from the Global Burden of Disease 2013
study to derive an under-5 mortality scaling factor [2]. This
scaling factor was then applied to state-level estimates.
Overall intervention coverage
We constructed an overall intervention coverage metric
to examine levels and trends across multiple key MCH
indicators that reflect the priorities of Nigeria’s health
system. This metric included 11 interventions: three
malaria interventions (household ownership of ITNs
and/or IRS, IPTp2 coverage, and receipt of ACTs among
febrile children), four childhood vaccines (BCG, measles,
OPV3, and DPT3), and four other MCH indicators
(ANC4, SBA, EBF, and the proportion of children under
5 who were not wasted). Each indicator was equally
weighted for the overall intervention coverage metric,
which was based on the average of the 11 indicators.
Ethical approval
Ethical approval for this study was obtained from the insti-
tutional review board of the University of Washington.
The study was conducted in compliance with national
regulatory and ethics guidelines. Any personal identifiers
collected during survey administration were removed be-
fore household surveys were made publicly available; as a




Nationally, under-5 mortality decreased by 30% from 2000
to 2013, declining from 184 deaths per 1,000 live births
(95% CI, 178–191) in 2000 to 128 deaths per 1,000 live
births (95% CI, 114–142) in 2013 (Fig. 1). Under-5 mortal-
ity rates fell in every state, with the range between states
narrowing from 2000 to 2013. In 2000, the state-level dif-
ference in under-5 mortality was 206, ranging from 96
deaths per 1,000 live births in Lagos (95% CI, 82–114) to
302 deaths per 1,000 live births in Zamfara (95% CI, 258–
349). By 2013, this difference shrunk to 137, ranging
from 72 deaths per 1,000 live births in Edo (95% CI, 52–
95) to 209 deaths per 1,000 live births in Zamfara (95%
CI, 160–269). Despite large gains in under-5 survival,
Zamfara consistently has had the highest state-level
under-5 mortality in Nigeria since 2000.
Figure 1 shows that, for the most part, states with
higher under-5 mortality in 2000 recorded the largest
declines by 2013. Nevertheless, regional patterns ofinequality persisted, with states in the North West and
North East zones still experiencing much higher rates of
under-5 mortality in 2013 than those located in southern
areas (Fig. 2). In 2013, seven northern states had under-
5 mortality rates exceeding 150 deaths per 1,000 live
births, similar to national rates experienced by countries
with the highest levels of under-5 mortality worldwide
(Guinea Bissau [153 deaths per 1,000 live births], Mali
[149 deaths per 1,000 live births], and Chad [147 deaths
per 1,000 live births]) [2]. In contrast, under-5 mortality
in 2013 was around 70 deaths per 1,000 live births in
Edo, Lagos, and Oyo. While these states had the lowest
levels of under-5 mortality in Nigeria in 2013, they still
remained twice as high as rates recorded by several
other sub-Saharan African countries (e.g. Botswana [31
deaths per 1,000 live births] and Namibia [35 deaths per
1,000 live births]) [2].Child nutrition
Our results showed a small, though not statistically sig-
nificant, increase in the proportion of children who were
underweight in Nigeria, from 23% (95% CI, 21–25%) in
2000 to 26% (95% CI, 24–28%) in 2013. At the state
level, results were mixed in terms of decreasing and ris-
ing rates of childhood underweight from 2000 to 2013,
though for most states the change was not statistically
significant during this time (Fig. 3). States with high
prevalence of underweight children in 2000, primarily in
the North West and North East zones of the country,
saw increases in prevalence while those with the lowest
levels in 2000 experienced moderate progress. Of note,
Kaduna and Cross River states had very similar rates of
childhood underweight in 2000, but Kaduna state experi-
enced one of the largest increases in prevalence between
2000 and 2013, while Cross River state showed the largest
decrease. These trends point to widening inequalities
across Nigeria, as rates of underweight children ranged
from 7% in Enugu (95% CI, 6–9%) to 47% in Kebbi (95%
CI, 33–62%) in 2013.
Other indicators of child nutrition pointed to signs of
moderate progress at the national level, though these
changes also were not statistically significant. For in-
stance, at the national level, the proportion of children
who were stunted declined from 39% in 2000 (95% CI,
37–41%) to 35% in 2013 (95% CI, 33–37%), and rates of
wasting decreased from 18% (95% CI, 16–20%) to 16%
(95% CI, 14–17%) during this time. Across states, re-
gional patterns more closely followed those found for
rates of childhood underweight, with trends implying
rising prevalence of stunting in some northern states.
The prevalence of wasting remained fairly unchanged
over time across states, although some recorded moder-
ate declines in wasting (Additional file 2).
Fig. 1 Trends in under-5 mortality by state, 2000–2013. Note: Each line represents a state grouped by geopolitical zone. The black line represents
the national trend for under-5 mortality
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Malaria control
Nationally, ITN ownership increased from near zero
in the early 2000s to 48% in 2013 (95% CI, 41–55%).
Most of these gains were driven by rising levels of
ITN coverage occurred after 2009, when a number of
state-level ITN distribution campaigns began. Across
states, ITN or IRS ranged from 3% in Benue (95%Fig. 2 Under-5 mortality by state in 2013CI, 1–13%) to 35% in Gombe (95% CI, 6–82%) in 2009.
By 2013, the range in coverage widened, spanning from
23% in Osun (95% CI, 5–63%) to 75% in Adamawa
(95% CI, 21–97%; Fig. 4). The geographic patterns for
ITN or IRS coverage varied substantially compared to
the trends observed for other indicators, such that ITN
or IRS coverage was generally much higher in areas with
lower levels of non-malaria interventions.
Fig. 3 Percentage of children under 5 who are underweight by state in 2000 and 2013
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reaching 20% nationally in 2013 (95% CI, 15–25%)
and ranging from 4% in Edo (95% CI, 0–27%) to 48%
in Niger (95% CI, 18–82%). Nigeria implemented
ACTs as the first-line treatment against uncompli-
cated malaria in 2005 [45], yet the receipt of ACTs2009
Fig. 4 Household ownership of insecticide-treated nets or receipt of indooamong children under 5 with suspected malaria also
remained very low in 2013, at 9% nationally (95% CI,
6–13%). All states had rates of ACT coverage below
25% in 2013, with Rivers recording the highest at 20%
(95% CI, 4–57%). Additional file 2 provides more results







r residual spraying, or both, by state in 2009 and 2013
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across all malaria interventions; instead, most of the states
with higher levels of ITN or IRS coverage recorded relatively
lower rates of IPTp2 and ACTcoverage, and vice versa.
Childhood immunizations
Vaccination rates for measles, DPT3, and OPV3 in-
creased in Nigeria from 2000 to 2013; however, Nigeria’s
absolute levels of coverage remained low with no vaccine
exceeding 65% coverage nationally. Coverage trends var-
ied substantially by geographic region and vaccine.
Nationally, measles immunization coverage rose from 44%
in 2000 (95% CI, 41–46%) to 55% in 2013 (95% CI, 52–
57%), though state-level vaccination rates ranged from 8% in
Sokoto (95% CI, 3–18%) to 92% in Ekiti (95% CI, 86–96%)
that year. While most states experienced increases in mea-
sles immunization coverage between 2000 and 2013, 14
states recorded declines in coverage after 2005. Oyo had
one of the most notable drops in measles immunization,
falling from 78% in 2005 (95% CI, 70–85%) to 68% in
2013 (95% CI, 58–80%). More results on measles
immunization coverage can be found in Additional file 2.
State-level trends in coverage for DPT3 and OPV3, both
vaccines with similar dosing requirements and immunizationFig. 5 Changes in OPV3 and DPT3 immunization coverage by state from 2schedules [54, 55], were particularly heterogeneous. Figure 5
shows coverage rates of DPT3 and OPV3 for every state,
grouped by geopolitical zone, for 2000 and 2013. Increases
in OPV3 coverage were particularly pronounced for several
states in North West and North East, which traditionally
have been high-priority targets for Nigeria’s polio elimination
campaigns [56]. Increased DPT3 coverage lagged behind the
gains recorded for the receipt of OPV3. For instance, in
Kebbi and Katsina, the difference between coverage of OPV3
and DPT3 exceeded 50 percentage points. By contrast, many
states in the North Central and South South zones recorded
similar increases in OPV3 and DPT3 coverage over time. In
a number of southern states, DPT3 immunization coverage
exceeded OPV3 vaccination rates. In Lagos state, DPT3
coverage was 19 percentage points higher than OPV3 cover-
age, with 88% DPT3 coverage (95% CI, 76–94%) and 69%
OPV3 coverage (95% CI, 48–83%). Further, state-level differ-
ences in coverage varied for these two vaccines. In 2013,
DPT3 immunization rates spanned from 3% in Sokoto (95%
CI, 1–9%) to 88% in Ekiti (95% CI, 78–94%) and 88% in
Lagos (95% CI, 76–94%). Conversely, the gap narrowed be-
tween states with the highest and lowest levels of OPV3
coverage over time, decreasing from a difference of 59 per-
centage points in 2000 and 33 percentage points in 2013.000 to 2013
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For more routine MCH services, Nigeria largely experi-
enced minimal progress or declines in coverage between
2000 and 2013; however, most decreases in coverage
were not statistically significant. Nationally, ANC cover-
age somewhat decreased since 2000, slipping to 71% for
ANC1 (95% CI, 69–72%) and 61% for ANC4 (95% CI,
59–62%) by 2013. Coverage of SBA and IFD was typic-
ally lower than ANC indicators, particularly in the North
East and North West zones. Nationally, EBF coverage
was 15% in 2013 (95% CI, 13–18%), well below Nigeria’s
EBF target of 38% for 2013 [10]. Across states, coverage
inequalities remained high for ANC, IFD, and SBA. For
instance, we found a difference of 86 percentage points
between the state with the highest levels of IFD in 2013
(Imo, at 91% [95% CI, 87–95%]) and the state with the
lowest (Zamfara, at 5% [95% CI, 2–12%]).
Several states also experienced potential gaps in the
continuum of care for maternal health services. One ex-
ample is the gap in coverage between ANC1 and ANC4
(Fig. 6), which may reflect challenges in ensuring that
pregnant women receive the recommended four ANC
visits [10, 57]. For instance, Kano’s coverage of ANC1Fig. 6 ANC1 and ANC4 coverage by state in 2013was 71% in 2013 (95% CI, 63–78%), but its rates of
ANC4 were much lower, at 47% (95% CI, 38–56%). By
contrast, this difference was much lower for many states
in the South East zone. Ondo recorded rates of ANC1
and ANC4 at 77% (95% CI, 69–84%) and 76% (95% CI,
67–84%), respectively. Over time, the relationship between
ANC1 and ANC4 varied widely across states. Many states,
such as Kwara and Enugu, saw coverage of ANC4 become
closer to ANC1 since 2000, whereas others saw coverage
gaps widen. Several states experienced declines in both
ANC1 and ANC4 coverage, but with the latter falling
faster, emphasizing the importance of monitoring various
indicators along continuums of care.Overall intervention coverage
Based on 11 high-priority MCH interventions in Nigeria,
we found that overall intervention coverage varied dras-
tically across states and within geopolitical zones
(Fig. 7a). States in the North West zone had some of the
country’s lowest levels of overall intervention coverage
in 2013, ranging from 21% in Sokoto to 39% in Kaduna.
Among these states, coverage was high for a subset of
AB
Fig. 7 Overall intervention coverage in 2013 (a) and change in overall intervention coverage from 2000 to 2013 (b). Note: The relative
contribution of each individual intervention is shown within each state bar. In (b), bar height represents the absolute change, in percentage
points, for overall intervention coverage from 2000 to 2013
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immunization); for other interventions, however,
coverage remained low. Eight states, largely located in
the South East and South South zones, and the
Federal Capital Territory had overall intervention
coverage equaling or exceeding 60% in 2013, with Ekiti
recording the highest level of coverage (66%). For
these states, the relative contribution of each interven-
tion was more balanced across MCH indicators.
Figure 7a clearly shows that EBF was the intervention
with consistently low levels of coverage across all states
in Nigeria.
Overall intervention coverage increased for all states
between 2000 and 2013, but how each intervention con-
tributed to – or detracted from – these gains varied
across Nigeria (Fig. 7b). Rising coverage of ITNs or IRS
was the main driver of improved overall intervention
coverage for most states. Increasing immunization rates
also contributed to this progress, particularly in the
North West zone. At the same time, several states had
marked declines in coverage for ANC4 and SBA, which
hindered further state-level gains in overall intervention
coverage. A number of states, largely in the North West
zone, also experienced rising rates of wasting among
children under 5. Overall growth among states varied
from approximately 5 to 23 percentage points, reflecting
the diverse nature of Nigeria’s state-level health
landscapes.
Discussion
This study represents the first-ever assessment of state-
level trends for a range of MCH interventions and out-
comes in Nigeria, highlighting the country’s mixture of
progress and ongoing challenges in improving local
health service provision. Every state recorded declines in
under-5 mortality – a major success – yet, absolute rates
of child deaths still ranked among the highest in sub-
Saharan Africa [2]. For a subset of malaria interventions,
coverage increased substantially between 2009 and 2013;
however, coverage remained quite low, particularly for
IPTp2 and ACTs, a cause for concern given Nigeria’s
large malaria burden [4]. Coverage of certain immuniza-
tions increased, especially for OPV3, an important result
given Nigeria’s aims to end wild polio transmission [56].
At the same time, similar gains were not actualized for
DPT3 coverage across states, suggesting that more rou-
tine delivery platforms for multi-dose vaccines may be
faltering amid disease-focused immunization campaigns
[40, 58]. Coverage of other key MCH interventions, such
as ANC4 and SBA, generally stagnated or declined, and
stark differences in coverage have persisted across states
since 2000. Benchmarking state-level performance for
MCH indicators demonstrated the continued entrench-
ment of North-South differences, particularly for moreroutine services, and showed that overall intervention
coverage generally remained low despite recent gains for a
subset of MCH interventions.
Nigeria’s state-level trends in under-5 mortality likely
reflect the complex nature of improving health out-
comes amid local changes in health system access, deliv-
ery of services, broader socio-economic gains, and
overall development. While all states experienced reduc-
tions in under-5 mortality between 2000 and 2013, it is
unlikely that these gains were driven by the same factors
in each state. In states where malaria transmission is
particularly high and coverage of ITNs increased, such
as Bauchi, improved childhood survival may be attribut-
able to expanded malaria control programming. In con-
trast, in urban areas where malaria transmission is
somewhat lower and women’s educational attainment
rose since 2000, such as Edo, socio-economic advances
may play a stronger role in reducing under-5 deaths.
Assessing how different intervention packages and
socio-economic forces are contributing the largest gains
in childhood survival – and doing so at local levels – is
critical to accelerating improved health throughout
Nigeria. For disease-specific programs that feature well-
funded, focused campaigns (namely malaria and polio)
[5–7], the scale-up of intervention coverage was less var-
ied across states. For instance, by 2013, many states in
more rural, poor areas reached levels of OPV3 coverage
found in the wealthier states of Nigeria. Although abso-
lute levels of immunization coverage remained lower
than optimal, the gap between states with the highest
and lowest levels of coverage narrowed over time. Con-
versely, inequalities in the coverage of several MCH in-
terventions and services provided through more routine
platforms continued across states, often following geo-
graphic patterns for urbanicity, wealth, and educational
attainment [32, 59]. These findings suggest that barriers
to accessing and using health services likely remain in
many states, particularly those in more remote, impover-
ished areas. These factors involve ongoing violence in
northern Nigeria [60–62]; demand-side influences (prox-
imity to facilities and care [63–65], affordability of trans-
portation to health facilities [66], cost of health care [67],
knowledge of available services and trust in providers [28],
religious views or cultural mores [68, 69]); and supply-side
dynamics (availability of skilled medical staff and their in-
teractions with patients [70–72], inconsistent stocks of
pharmaceuticals and medical supplies across levels of care
[73–75], inadequate facility infrastructure [76]). In com-
bination, these factors may have a compounding effect
on hindering health-care-seeking behaviors. Additional
work on identifying which of these factors are most eas-
ily affected by policy levers and programs promoting
heighted utilization of routine services in Nigeria should
be prioritized.
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age, particularly when compared to trends in DPT3 vac-
cination rates, highlight the differences in the country’s
health system functions across specific interventions. As
one of the last polio-endemic countries in the world,
Nigeria has received tremendous resources and policy
attention for eliminating polio, especially through the
GPEI [56, 77]. Due to targeted immunization campaigns
and developing disease surveillance structures [56, 78,
79], Nigeria increased OPV3 immunization coverage by
25 percentage points since 2000 and created a strong
detection-response system for finding its remaining
polio cases. Such progress is particularly impressive
given that Nigeria has experienced tensions and violence
around polio vaccination, notably culminating in boy-
cotts of immunization campaigns in Kano, Zamfara,
and Kaduna in 2003 and 2004 [80, 81], and multiple
shootings in 2013 [82]. On the contrary, Nigeria saw
minimal progress for DPT3 immunization rates, an-
other three-dose vaccine that is delivered through
more routine EPI services rather than mass cam-
paigns. This contrast with Nigeria’s gains in OPV3
coverage reflects how program-focused investments and
commitment can likely improve vaccination rates, as well
as possible missed opportunities for integrating service
delivery [55, 58].
Diverging state-level trends for MCH interventions re-
vealed geographic disparities along a continuum of care
for maternal health services. In a health system where
both demand and supply for health services are strong,
we might expect to see similar coverage levels for
ANC1, ANC4, SBA, and IFD, or that women have least
four ANC visits prior to delivery and give birth in a
health facility and/or in the presence of skilled attendant
[83]. We found that a subset of states, largely located in
the southern regions of Nigeria, appeared to have strong
linkages between these services, experiencing minimal
differences in coverage for ANC1 and ANC4, for ex-
ample. However, the majority of states saw some kind of
breakdown in this MCH service continuum. These find-
ings point to two related but separate challenges to bol-
stering Nigeria’s continuum of care for MCH services:
(1) improving the frequency of ANC visits and (2) culti-
vating stronger demand and capacity for giving birth
with skilled birth attendants or in health facilities. Previ-
ous research has identified cost, transportation, and cap-
acity of the health facility as barriers for women seeking
ANC services [84, 85] and SBA [14, 86, 87]. Local health
authorities may consider expanding and scaling up exist-
ing programs which include outreach campaigns, im-
proving facility-based resources for ANC and routine
deliveries, and innovative incentive structures, such as
conditional cash transfers, that explicitly link ANC to
post-natal services [1, 14, 16, 88–91].This study further demonstrates the importance of
setting ambitious yet realistic health system goals, as
well as approaching such target-setting with an equity
lens. Nigeria established several high-reaching health
program goals to improve MCH outcomes, which in-
cluded achieving 80% ITN coverage by 2013 [92], 78%
DPT3 coverage by 2013 [54], and rates of 38% for EBF
by 2013 [10]. We found that national coverage of these
interventions – 47% for ITN ownership, 46% for DPT3,
and 15% for EBF – registered well below the country’s
targets in 2013. While a few states met or exceeded
these targets for EBF and DPT3 (e.g., Osun and Ekiti
had EBF rates exceeding 40% in 2013), most states fell
quite short of the country’s health program goals. Many
of these targets may have been overly ambitious given
baseline levels of intervention coverage (e.g., at 14%
ITN ownership in 2009, Nigeria remained 66 percentage
points away from its goal of 80% in 2013); at the same
time, Nigeria’s goals align with global recommendations
and targets for improving priority MCH outcomes (e.g.
the MDGs). To accelerate Nigeria’s progress toward its
health system goals for 2015 and beyond, a heightened
focus on the country’s most disadvantaged populations
will be required. EBF, for example, is considered highly
cost-effective for improving childhood survival, requires
minimal investments in health system infrastructure to
scale up, and has been expanded rapidly in other Afri-
can countries [42]; thus, strengthening educational out-
reach about EBF [93] and expanding facility-based
breastfeeding programs, such as the Baby Friendly Hos-
pital Initiative [94], across levels of care may promote
better child health outcomes in states with low levels of
EBF. Without a greater focus on local health needs and
addressing Nigeria’s persistent health inequalities, the
gaps between states with the highest and lowest levels
of intervention coverage will likely widen over time.
This finding also emphasizes the need for incorporating
explicit equity goals within the next generation of inter-
national target-setting with the Sustainable Development
Goals [95].
Our findings correspond with recent policy develop-
ments in Nigeria, namely the National Health Bill’s en-
actment in December 2014 [17]. This bill aims to
address many of the MCH indicators analyzed in our
study, with leadership claiming that its effective imple-
mentation will save over 3 million “lives of mothers,
newborns, and under-5’s by 2022” [96]. The National
Health Bill’s success hinges upon successful execution
throughout Nigeria, a feat that has challenged the coun-
try’s past health reforms [11, 12, 97]. The use of subna-
tional benchmarking to monitor indicators related to
the National Health Bill will be critical for tracking
local progress, promptly identifying obstacles in
implementation, and building local accountability
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strengthening local health information systems,
namely Nigeria’s District Health Information System
(DHIS2) [98], and expanding the types of indicators
captured by these systems (e.g. data pertaining to non-
communicable diseases).Limitations
Our findings need to be interpreted within the context
of some study limitations. First, we were unable to esti-
mate trends for a number of priority MCH indicators
due to data scarcity. For instance, we were unable to
generate intervention estimates for HIV/AIDS treatment
or case management of pneumonia as they were not
captured by data sources that met inclusion criteria. Es-
timates of state-level maternal deaths also could not be
appropriately generated due to small numbers. Second,
our results do not reflect the quality of interventions re-
ceived, which is a critical input for understanding
whether interventions are effectively provided and thus
result in their intended health gains. Third, most indica-
tors were based on self-reports from survey respondents,
and thus may be prone to various self-report biases.
Fourth, our results provide minimal information about
supply-side factors that affect health service provision,
such as facility stocks of pharmaceuticals and medical
supplies, human resources for health, and facility infra-
structure. With the expansion of DHIS2 and recent re-
lease of Nigeria’s MDG Information System [33], it is
possible that future analyses may account for such
supply-side influences. Fifth, our findings were limited
to state-level analyses due to geographic data restric-
tions. In the future, it would be ideal to track health
trends at the LGA- or ward-level and stratified by wealth
quintiles to provide more localized, actionable results.
Finally, our study was descriptive in nature, and thus
could not provide insights into the causes of gains, de-
clines, and differences in state-level performance over
time. Evaluating the underlying drivers of these changes
over time and across states would provide invaluable in-
sights into which types of programs work – and which
do not – to improve health outcomes.Conclusions
With this study we implemented a systematic framework
to harness available data and generate comparable trends
of priority MCH outcomes and interventions over time.
We found that Nigeria made notable gains for a subset
of MCH indicators between 2000 and 2013, but also ex-
perienced stalled progress and even declines for others.
Despite progress for a subset of indicators, Nigeria’s ab-
solute levels of intervention coverage remained quite
low. As Nigeria rolls out its National Health Bill andseeks to strengthen its delivery of health services, con-
tinued monitoring of local health trends will help policy-
makers track successes and promptly address challenges
as they arise. Subnational benchmarking ought to occur
regularly in Nigeria and throughout sub-Saharan Africa
to inform local decision-making and bolster health
system performance.
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